« Back
Home /
Piribedil

Piribedil

Manufacturer	MedChem Express
Category	Metabolism Diabetes Glucose Homeostasis Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	10mM/1mL
Item no.	HY-12707-10mM
Targets	Adrenergic Receptor; Dopamine Receptor
CASRN	3605-01-4
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Piribedil is a potent and orally active dopamine D2 and dopamine D3 agonist. Piribedil is also a α2-adrenoceptors antagonist. Piribedil can inhibit MLL1 methyltransferase activity (EC50: 0.18 μM). Piribedil has the potential for the research of parkinson's disease, circulatory disorders, cancers[1][2][3][4].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Neuroscience-Neuromodulation
MolecularWeight	298.34
Clinical_Information	Launched
Manufacturers Research_Area	Cancer; Endocrinology; Neurological Disease
Solubility	DMSO : 33.33 mg/mL (ultrasonic)
Manufacturers Target	Adrenergic Receptor; Dopamine Receptor; Histone Methyltransferase
Isoform	D2 Receptor; D3 Receptor; α adrenergic receptor
Pathway	Epigenetics; GPCR/G Protein; Neuronal Signaling
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12707-10mM-safety-datasheet.pdf